
### [NCIT:C4845](http://purl.obolibrary.org/obo/NCIT_C4845)
**Label:** Pancreatic Intraepithelial Neoplasia

**Subclasses:** [NCIT:C95429](http://purl.obolibrary.org/obo/NCIT_C95429) (Pancreatic Intraepithelial Neoplasia-1A), [NCIT:C4846](http://purl.obolibrary.org/obo/NCIT_C4846) (Pancreatic Intraepithelial Neoplasia-2), [NCIT:C6820](http://purl.obolibrary.org/obo/NCIT_C6820) (Pancreatic Intraepithelial Neoplasia-1), [NCIT:C95432](http://purl.obolibrary.org/obo/NCIT_C95432) (Pancreatic Intraepithelial Neoplasia-3), [NCIT:C95430](http://purl.obolibrary.org/obo/NCIT_C95430) (Pancreatic Intraepithelial Neoplasia-1B), 

**Class expressions from DL-Learner:**

- Thing 53.25%
- [NCIT:C8329](http://purl.obolibrary.org/obo/NCIT_C8329) (Severe Cytologic Atypia) 53.12%
- [NCIT:C8328](http://purl.obolibrary.org/obo/NCIT_C8328) (Moderate Cytologic Atypia) 53.12%
- [NCIT:C8327](http://purl.obolibrary.org/obo/NCIT_C8327) (Mild Cytologic Atypia) 53.12%
- [NCIT:C7693](http://purl.obolibrary.org/obo/NCIT_C7693) (Precancerous Atypia) 53.12%
- [NCIT:C41361](http://purl.obolibrary.org/obo/NCIT_C41361) (KRAS Gene Mutation) 53.12%
- [NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation) 53.12%
- [NCIT:C36693](http://purl.obolibrary.org/obo/NCIT_C36693) (SMAD4/DPC4 Gene Inactivation) 53.12%
- [NCIT:C36689](http://purl.obolibrary.org/obo/NCIT_C36689) (BRCA2 Gene Inactivation) 53.12%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 53.12%
- [NCIT:C25785](http://purl.obolibrary.org/obo/NCIT_C25785) (KRAS Gene) 53.12%
- [NCIT:C18258](http://purl.obolibrary.org/obo/NCIT_C18258) (SMAD4 Gene) 53.12%
- [NCIT:C18120](http://purl.obolibrary.org/obo/NCIT_C18120) (BRCA2 Gene) 53.12%
- [NCIT:C18022](http://purl.obolibrary.org/obo/NCIT_C18022) (CDKN2A Gene) 53.12%
- [NCIT:C17359](http://purl.obolibrary.org/obo/NCIT_C17359) (TP53 Gene) 53.12%


